New drug tested in race against recurrent brain cancer
Disease control
Recruiting now
This early study is testing whether the drug troriluzole can help control recurrent glioblastoma, an aggressive brain cancer. About 27 adults whose cancer has returned will receive the drug either before and after standard tumor-removal surgery, or only after surgery, to see if i…
Phase: EARLY_PHASE1 • Sponsor: Ugonma Chukwueke • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC